NanoViricides Inc. (NNVC)

[arvitar]

Just 20 months until bankruptcy.

And according to the FDA, at least 9 years away from an approved NDA and marketable product, assuming Seymour & Diwan aren't lying about their "cure-machine".

Also, the Company has incurred significant operating losses since its inception, resulting in an accumulated deficit of $64,824,201 at June 30, 2016. Such losses are expected to continue for the foreseeable future. The Company estimates that it has sufficient cash to support current operations through the next two years, i.e. through June, 2018.

p. 21 http://ih.advfn.com/p.php?pid=nmona&article=72455572